Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/21622718

Clin. Cancer Res. 2011 Jul 1 17 13 4425-38

Download in:

View as

General Info

PMID
21622718